The moment everything changed wasn't Marybeth Gilliam's first breast cancer diagnosis.
It was the second.
More than a decade after being diagnosed with early-stage breast cancer, Marybeth found herself facing metastatic disease and a startling realization. Some of the most important research relevant to her cancer journey existed in scientific journals and conferences, but many patients never hear about it.
That discovery sent her on a mission to understand the science behind her disease, advocate for herself, and help other patients do the same. Today, through her work with Outperform Cancer, Marybeth is helping people bridge the gap between cutting-edge research and real-world cancer care.
About the Guest
Marybeth Gilliam is the founder of Outperform Cancer, a patient advocacy and education platform focused on helping people better understand emerging cancer research, biomarker testing, and precision medicine.
After experiencing both an early-stage breast cancer diagnosis and a later metastatic recurrence, Marybeth immersed herself in the science of oncology to better understand her own treatment options. Her experience revealed a significant gap between what researchers know and what many patients are told, inspiring her to create resources that empower patients to become active participants in their care.
Through Outperform Cancer, she helps patients navigate complex medical information, understand new research findings, and have more informed conversations with their healthcare teams.
Website: Outperform Cancer
Pull Quote
“There is a gap between what cancer researchers know and what patients know.”
